De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement.
De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement.
复制标题
DOI:
10.1016/j.ajhg.2022.09.005
复制
发表时间:
2022-10
影响因子:
9.8
通讯作者:
Shenzhao Lu;Mengqi Ma;Xiao Mao;C. Bacino;J. Jankovic;V. Sutton;J. Bartley;Xueying Wang;J. Rosenfeld;A. Beleza‐Meireles;Jaynee Chauhan;Xueyang Pan;Megan Li;Pengfei Liu;K. Prescott;Sam Amin;George Davies;M. Wangler;Yuwei Dai;H. Bellen
中科院分区:
文献类型:
--
作者:
Shenzhao Lu;Mengqi Ma;Xiao Mao;C. Bacino;J. Jankovic;V. Sutton;J. Bartley;Xueying Wang;J. Rosenfeld;A. Beleza‐Meireles;Jaynee Chauhan;Xueyang Pan;Megan Li;Pengfei Liu;K. Prescott;Sam Amin;George Davies;M. Wangler;Yuwei Dai;H. Bellen
Proteins containing the FERM (four-point-one, ezrin, radixin, and moesin) domain link the plasma membrane with cytoskeletal structures at specific cellular locations and have been implicated in the localization of cell-membrane-associated proteins and/or phosphoinositides. FERM domain-containing protein 5 (FRMD5) localizes at cell adherens junctions and stabilizes cell-cell contacts. To date, variants inFRMD5have not been associated with a Mendelian disease in OMIM. Here, we describe eight probands with rare heterozygous missense variants inFRMD5who present with developmental delay, intellectual disability, ataxia, seizures, and abnormalities of eye movement. The variants arede novoin all for whom parental testing was available (six out of eight probands), and human genetic datasets suggest thatFRMD5is intolerant to loss of function (LoF). We found that the fly ortholog ofFRMD5,CG5022 (dFrmd), is expressed in the larval and adult central nervous systems where it is present in neurons but not in glia.dFrmdLoF mutant flies are viable but are extremely sensitive to heat shock, which induces severe seizures. The mutants also exhibit defective responses to light. The humanFRMD5reference (Ref) cDNA rescues the flydFrmdLoF phenotypes. In contrast, all theFRMD5variants tested in this study (c.340T>C, c.1051A>G, c.1053C>G, c.1054T>C, c.1045A>C, and c.1637A>G) behave as partial LoF variants. In addition, our results indicate that two variants that were tested have dominant-negative effects. In summary, the evidence supports that the observed variants inFRMD5cause neurological symptoms in humans.